A. Sabiniarz

发表

A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia

G. Dubin, J. Tamburini, M. Szydłowski, 2018, Oncotarget.

Development of selective MELK kinase inhibitors for breast cancer treatment

D. Ito, P. Zhu, N. Larsen, 2016 .

Investigations on the synthesis and pharmacological properties of 4-alkoxy-2-[2-hydroxy-3-(4-aryl-1-piperazinyl)propyl]-6-methyl-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones.

Z. Kleinrok, M. Sieklucka-Dziuba, T. Lis, 2002, Farmaco.

Discovery and Structure–Activity Relationships of N‐Aryl 6‐Aminoquinoxalines as Potent PFKFB3 Kinase Inhibitors

M. Jurzak, M. Nowak, M. Kujawa, 2018, ChemMedChem.

5-Keto-3-cyano-2,4-diaminothiophenes as selective maternal embryonic leucine zipper kinase inhibitors.

M. Milik, M. Żurawska, Karolina Gluza, 2019, Bioorganic & medicinal chemistry letters.

Chromatographic Separation of Derivatives of 4‐Alkoxy‐6‐methyl‐1H‐pyrrolo[3,4‐c]pyridine‐1,3(2H)‐dione by TLC and HPLC

P. Górski, D. Szkatuła, I. Muszalska, 2007 .

HPLC and TLC methodology for determination or purity evaluation of 4-methoxy-2-(3(4-phenyl-1-piperazinyl))propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine.

I. Muszalska, A. Sabiniarz, H. Śladowska, 2005, Acta poloniae pharmaceutica.

Synthesis of amide and sulfonamide substituted N-aryl 6-aminoquinoxalines as PFKFB3 inhibitors with improved physicochemical properties.

M. Jurzak, M. Nowak, M. Kujawa, 2019, Bioorganic & medicinal chemistry letters.

Discovery and Structure-Activity Relationships of N-Aryl 6-Aminoquinoxalines as Potent PFKFB3 Kinase Inhibitors.

M. Jurzak, M. Nowak, M. Kujawa, 2018 .

Synthesis and pharmacological properties of N,N-dialkyl(dialkenyl)amides of 7-methyl-3-phenyl-1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-5-carboxylic acid.

B. Filipek, D. Maciąg, M. Kardasz, 2003, Farmaco.

Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 4

M. Nowak, M. Mikulski, H. Eggenweiler, 2019 .